MiNK Therapeutics, Inc.
INKT
$14.72
-$0.44-2.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 52.69% | 51.98% | 44.36% | 34.23% | 20.52% |
| Total Depreciation and Amortization | -0.19% | 5.23% | 13.81% | 25.69% | 51.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.31% | -84.58% | -69.84% | 3.01% | 779.71% |
| Change in Net Operating Assets | -86.41% | -84.13% | -58.99% | -59.60% | -50.17% |
| Cash from Operations | 40.06% | 39.38% | 36.68% | 34.93% | 26.78% |
| Capital Expenditure | -- | -- | 100.00% | 90.34% | 77.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 90.34% | 77.23% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18,124.76% | 8,155.32% | 8,143.63% | 8,440.68% | -31.25% |
| Repurchase of Common Stock | 100.00% | 100.00% | 100.00% | 100.00% | 81.81% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.82% | 2,757.82% | 2,758.48% | 2,741.32% | 1,105.54% |
| Foreign Exchange rate Adjustments | -288.79% | -116.67% | -554.24% | -65.03% | -101.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.55% | 107.44% | 99.60% | 93.19% | 54.16% |